Drug Trial Radar · NCT01211145
Zomig - Treatment of Acute Migraine Headache in Adolescents
Last checked: Nov 20, 2026Latest source record: May 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,653
Actual
Start
Sep 2010
Primary completion
Oct 2013
Study completion Oct 2013
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Sep 29, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).
Conditions
- Migraine Headache
Interventions
PlaceboDrug
Placebo nasal spray
ZolmitriptanDrug
0.5 mg nasal spray
ZolmitriptanDrug
2.5 mg nasal spray
ZolmitriptanDrug
5.0 mg nasal spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain-free Status at 2 Hours Post-treatmentTime frame: 2 hours post-treatment.
Locations
74 sites in 8 countries. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona
Research Site
Fresno, California
Research Site
Fullerton, California
Research Site
Newport Beach, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
Centennial, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Thornton, Colorado
Research Site
Fairfield, Connecticut
Research Site
Boca Raton, Florida
Research Site
Hallandale, Florida
Research Site
Miami, Florida
Research Site
Miami Lakes, Florida
Research Site
North Palm Beach, Florida
Research Site
Orlando, Florida
Research Site
Tampa, Florida
Research Site
West Palm Beach, Florida
Research Site
Owensboro, Kentucky
Research Site
Worcester, Massachusetts
Research Site
Ann Arbor, Michigan
Research Site
Plymouth, Minnesota
Research Site
Ocean Springs, Mississippi
Research Site
Olive Branch, Mississippi
Research Site
Columbia, Missouri
Research Site
Springfield, Missouri
Research Site
St Louis, Missouri
Research Site
The Bronx, New York
Research Site
Cary, North Carolina
Research Site
Hickory, North Carolina
Research Site
Raleigh, North Carolina
Research Site
Akron, Ohio
Research Site
Cleveland, Ohio
Research Site
Toledo, Ohio
Research Site
Oklahoma City, Oklahoma
Research Site
Indiana, Pennsylvania
Research Site
Jackson, Tennessee
Research Site
Nashville, Tennessee
Research Site
San Antonio, Texas
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.